Sign In
Buy KPTI
$9.00
-0.230 (-2.49%)
At Close: Jun 03, 2026
Are Options Traders Betting on a Big Move in Karyopharm Therapeutics (KPTI) Stock?
12:32pm, Wednesday, 03'rd Jun 2020
Investors need to pay close attention to Karyopharm Therapeutics (KPTI) stock based on the movements in the options market lately.
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:05pm, Monday, 01'st Jun 2020
Karyopharm Therapeutics Inc. (KPTI), an innovation-driven pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s Board of Directors granted stock options to purchase
Best Buy has tons of Apple deals and more today – here are the 10 best ones
03:42pm, Monday, 01'st Jun 2020
Best Buy’s sale is one of the best ways to start off June, with tons of great deals to be found on top-selling product from Apple and more. Here, we have rounded up 10 of the very best deals …
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
12:00am, Monday, 01'st Jun 2020
Despite the FDA tied up with COVID-19-related activities, May turned out to be a positive month for biopharma companies from the perspective of drug approvals. Three new molecular...
Top Small Cap Stocks for June 2020
05:38pm, Friday, 29'th May 2020
Small cap stocks are listed companies that have market capitalizations typically ranging from $300 million to $2 billion. Since the share prices of these companies can have big fluctuations over a sh
Lady Gaga 'Chromatica' available to stream and download now
01:30pm, Friday, 29'th May 2020
Lady Gaga's Chromatica is now available for stream and download from all major music services having dropped on 29 May 2020.
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
11:22am, Friday, 29'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 28) * ADC Therapeutics SA (NYSE: ADCT) (IPOed May 15) * A
The
-- Combination of Once-Weekly XPOVIO® (selinexor), Once-Weekly Velcade® (bortezomib) and Dexamethasone (SVd) Prolonged Median Progression-Free Survival by 47% Compared to.
Karyopharm to Participate at Jefferies Virtual Healthcare Conference
08:05pm, Tuesday, 26'th May 2020
Karyopharm Therapeutics Inc. (KPTI), an innovation-driven pharmaceutical company, today announced that Michael Kauffman, MD, PhD, Chief Executive Officer, will participate in a fireside chat at the Je
Karyopharm Therapeutics Inc. (KPTI), an innovation-driven pharmaceutical company, today announced it will host an investor conference call to discuss detailed results from the pivotal, Phase 3 BOSTO
Karyopharm Therapeutics: Getting Paid Well For Accepting Uncertainty (NASDAQ:KPTI)
02:41am, Friday, 22'nd May 2020
The rule should be a reward for risk involvement. Understood, but not always achieved. How to score better: Bigger, more often, fewer losses? When uncertainty c
